Social Anxiety in Autistic Adults: Site Passes DEA Inspection

On July 2, 2015, the study site for our ongoing study of MDMA-assisted therapy for social anxiety in 12 autistic adults passed a routine inspection by the U.S. Drug Enforcement Administration (DEA). Sponsored by MAPS, this is a collaborative study between MAPS, the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, and researchers at Stanford University. Seven out of 12 subjects have now been treated in this study, which is exploring whether MDMA combined with therapy can enhance functional skills and quality of life in autistic adults with social anxiety. “The DEA visit was a routine inspection, and the process went quite smoothly,” reports Principal Investigator Charles Grob, M.D. “Recruitment is going well, and we are looking forward to conducting several treatment sessions over the next month.”